BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31751537)

  • 1. A
    De Filippo E; Hinz S; Pellizzari V; Deganutti G; El-Tayeb A; Navarro G; Franco R; Moro S; Schiedel AC; Müller CE
    Biochem Pharmacol; 2020 Feb; 172():113718. PubMed ID: 31751537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of extracellular cysteine residues in the adenosine A2A receptor.
    De Filippo E; Namasivayam V; Zappe L; El-Tayeb A; Schiedel AC; Müller CE
    Purinergic Signal; 2016 Jun; 12(2):313-29. PubMed ID: 26969588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells.
    Mundell SJ; Kelly E
    Biochem Pharmacol; 1998 Mar; 55(5):595-603. PubMed ID: 9515570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.
    Wolska N; Rozalski M
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A
    Hinz S; Navarro G; Borroto-Escuela D; Seibt BF; Ammon YC; de Filippo E; Danish A; Lacher SK; Červinková B; Rafehi M; Fuxe K; Schiedel AC; Franco R; Müller CE
    Oncotarget; 2018 Mar; 9(17):13593-13611. PubMed ID: 29568380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of endogenous A
    Goulding J; May LT; Hill SJ
    Biochem Pharmacol; 2018 Jan; 147():55-66. PubMed ID: 29106905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
    Feoktistov I; Biaggioni I
    Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A
    Hamilton LJ; Walker M; Pattabiraman M; Zhong HA; Luedtke B; Chandra S
    Pharmacol Res; 2021 Mar; 165():105410. PubMed ID: 33401004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of V6.51L as a selectivity hotspot in stereoselective A
    Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H
    Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
    Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.
    Labazi H; Teng B; Zhou Z; Mustafa SJ
    J Mol Cell Cardiol; 2016 Jan; 90():30-7. PubMed ID: 26654777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New substituted 9-alkylpurines as adenosine receptor ligands.
    Camaioni E; Costanzi S; Vittori S; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 1998 May; 6(5):523-33. PubMed ID: 9629466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.
    Teng B; Fil D; Tilley SL; Ledent C; Krahn T; Mustafa SJ
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):70-6. PubMed ID: 23288107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.
    Sanjani MS; Teng B; Krahn T; Tilley S; Ledent C; Mustafa SJ
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2322-33. PubMed ID: 21949117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
    Conti A; Lozza G; Monopoli A
    Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modelling of the human adenosine A2B receptor based on X-ray structures of bovine rhodopsin, the beta2-adrenergic receptor and the human adenosine A2A receptor.
    Sherbiny FF; Schiedel AC; Maass A; Müller CE
    J Comput Aided Mol Des; 2009 Nov; 23(11):807-28. PubMed ID: 19757091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential development of adenosine A1 and A2b receptors in the rat duodenum.
    Peachey JA; Hourani SM; Kitchen I
    Br J Pharmacol; 1996 Nov; 119(5):949-58. PubMed ID: 8922745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.
    Liang BT; Haltiwanger B
    Circ Res; 1995 Feb; 76(2):242-51. PubMed ID: 7834835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.